Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Sarilumab (L04Ac14) As Part Of A So-Called Open House Model.

AOK Rheinland-Pfalz Saarland - Die Gesundheitskasse Germany has Released a tender for Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Sarilumab (L04Ac14) As Part Of A So-Called Open House Model. in Healthcare and Medicine. The tender was released on Oct 11, 2023.

Country - Germany

Summary - Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Sarilumab (L04Ac14) As Part Of A So-Called Open House Model.

Deadline - Sep 30, 2025

GT reference number - 72959970

Product classification - Medical equipments, pharmaceuticals and personal care products